|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.090 CNY | -0.66% |
|
+6.69% | -14.08% |
| Market Cap | 4.38B 649M 563M 527M 482M 910M 61.78B 922M 6.17B 2.42B 30.87B 2.43B 2.38B 103B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.84B 420M 365M 341M 312M 590M 40.02B 597M 3.99B 1.57B 19.99B 1.58B 1.54B 66.55B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | -0.66% | ||
| 1 week | +6.69% | ||
| Current month | +3.30% | ||
| 1 month | -8.73% | ||
| 3 months | -16.76% | ||
| 6 months | -19.91% | ||
| Current year | -14.08% |
| 1 week | 8.73 |  | 9.23 |
| 1 month | 8.35 | | 10.66 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 16.25 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.66% | +6.69% | -38.71% | -14.97% | 649M | |
| +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | |
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | |
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | |
| +2.48% | +5.63% | +49.94% | +41.02% | 358B | |
| +1.13% | -0.17% | +35.82% | +40.66% | 293B | |
| +1.44% | -4.94% | +9.66% | +10.31% | 247B | |
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | |
| +4.72% | +0.65% | -0.11% | -43.47% | 200B | |
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | |
| Average | +0.56% | -1.38% | +25.21% | +44.86% | 359.29B | |
| Weighted average by Cap. | +0.23% | -0.83% | +41.25% | +78.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 61.69M 53.53M 50.13M 45.85M 86.57M 5.88B 87.7M 586M 230M 2.94B 232M 227M 9.77B | 405M 59.95M 52.02M 48.71M 44.56M 84.12M 5.71B 85.22M 570M 224M 2.85B 225M 220M 9.5B |
| Net income | -68.85M -10.2M -8.85M -8.29M -7.58M -14.31M -971M -14.5M -96.95M -38.05M -485M -38.29M -37.46M -1.62B | 14.57M 2.16M 1.87M 1.75M 1.6M 3.03M 206M 3.07M 20.52M 8.05M 103M 8.1M 7.93M 342M |
| Net Debt | -1.57B -233M -202M -189M -173M -327M -22.17B -331M -2.21B -868M -11.08B -874M -855M -36.88B | -1.54B -228M -198M -186M -170M -321M -21.76B -325M -2.17B -852M -10.87B -858M -839M -36.19B |
Employees
489
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | CN¥9.090 | -0.66% | 5,094,300 |
| 26-08-05 | CN¥9.150 | +0.11% | 5,462,205 |
| 26-08-04 | CN¥9.140 | +2.70% | 7,066,002 |
| 26-08-03 | CN¥8.900 | +1.14% | 4,687,800 |
| 26-07-31 | CN¥8.800 | +3.29% | 6,649,600 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
